Author

Kyoko Kikuno

Observed names: K Kikuno, K. Kikuno

Institutions: Gifu University Hospital, Gifu University

Observed institutions: Chiba University, Keio University, Gifu University Hospital, Gifu University

ORCID: 0009-0005-8903-3574

Observed ORCID: 0009-0005-8903-3574

OpenAlex ID: A5016941832

Human herpesvirus‐6 encephalitis after bone marrow transplantation: magnetic resonance imaging could identify the involved sites of encephalitis

1998 · H. Tsujimura, T. Iseki, et al. · European Journal Of Haematology · 39

Changes in serum erythropoietin and the reticulocyte count during chemotherapy for leukemias

1996 · Y. Sawabe, K. Kikuno, et al. · European Journal Of Haematology · 14

Changes in Levels of Serum Erythropoietin, Serum Iron and Unsaturated Iron Binding Capacity During Chemotherapy for Lung Cancer

1998 · Y. Sawabe, Y. Takiguchi, et al. · Japanese Journal of Clinical Oncology · 8

Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial

2025 · Kyoko Kikuno, Ryuta Asada, et al. · JMIR Research Protocols · 4

MRI characteristics of ovarian metastasis: differentiation from stomach and colorectal cancer

2024 · Yukiko Takai, Hiroki Kato, et al. · Japanese Journal of Radiology · 4

[Two patients with acute promyelocytic leukemia whose relapse was noted by cytodiagnosis of middle ear discharge].

1996 · K Kikuno, S Goto, et al. · PubMed · 3

[Molecular evidence for a single clonal origin in a patient with multiple myeloma and non-Hodgkin's lymphoma].

1995 · F Nagamura, S Goto, et al. · PubMed · 3

Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial

2025 · Kyoko Kikuno, Ryuta Asada, et al. · Advances in Therapy · 2

Modification of urinary secretion of 8-hydroxy-2'-deoxyguanosine and serum ACTH concentration following repetitive parabolic flights.

2001 · J Nomura, Y Arase, et al. · PubMed · 1

Patterns of Recurrence and Subsequent Treatment After First-line Parp Inhibitor Maintenance in Ovarian Cancer

2026 · Maria Hishida, Aika Genda, et al. · International Journal of Gynecological Cancer

Survival Outcomes of Parp Inhibitor Rechallenge in Recurrent Ovarian Cancer: a Multicenter Retrospective Study in Japan

2026 · Aika Genda, Maria Hishida, et al. · International Journal of Gynecological Cancer

Postoperative nausea and vomiting as a predictor of chemotherapy-induced nausea and vomiting in gynecologic cancer: a retrospective cohort study

2026 · Senri Yamamoto, Hirotoshi Iihara, et al. · Supportive Care in Cancer

Correction to: Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial

2025 · Kyoko Kikuno, Ryuta Asada, et al. · Advances in Therapy

[High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].

1993 · R Tanosaki, S Okamoto, et al. · PubMed

Works count: 14

Citation count: 78

H-index: 4

I10-index: 2